| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
3 companies
Topper James N serves as a Director at NAMS and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 17 buys and 0 sells. Those positions are worth an estimated $71.8M at current prices.
Historically, Topper James N's trades have earned a strong insider score of 89/100 across 14 rated trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +64.1%.
The biggest single holding is NAMS (~$71.8M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 28,324 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 660 | $23.70 | $15,638.90 | - | +46.6% | -12.3% | |
| Sep 8, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 1,260 | $24.99 | $31,487.40 | - | +42.5% | +2.2% | |
| Aug 11, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 471 | $23.98 | $11,293.97 | - | +59.9% | +13.3% | |
| Jun 25, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 3,780 | $18.38 | $69,466.07 | +0.1% | +45.5% | - | |
| Jun 16, 2025 | NAMS Newamsterdam Pharma Co N.V. | - | Buy | 8,584 | $19.50 | $167,381.13 | +0.3% | +22.1% | +52.9% | |
| May 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 3,780 | $3.86 | $14,609.32 | +6.8% | +166.2% | +196.9% | |
| May 14, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 7,420 | $3.30 | $24,462.49 | +15.4% | +219.4% | +301.5% | |
| May 12, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 48,203 | $3.17 | $152,916.63 | New | +226.3% | - | |
| Mar 26, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 1,135 | $22.49 | $25,520.59 | - | -18.4% | +38.5% | |
| Mar 4, 2025 | NAMS Newamsterdam Pharma Co N.V. | Director | Buy | 4,005 | $21.02 | $84,203.12 | +0.1% | -12.0% | +45.0% |